Breaking News

Pfizer Joins the TriNetX Global Research Network

Aims to improve clinical trial design and accelerate drug development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Pfizer Inc. has joined the TriNetX global health research network. As a member, Pfizer will have access to clinical data from TriNetX’s network of healthcare organizations to support clinical study and protocol design, site identification, and patient recruitment for clinical trials across a range of therapeutic areas and development stages.  TriNetX is a global health research network that connects healthcare organizations, biopharmaceutical companies, and CROs to collaborate to enhance tria...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters